133 related articles for article (PubMed ID: 2348378)
1. Bioavailability estimation by semisimultaneous drug administration: a Monte Carlo simulation study.
Karlsson MO; Bredberg U
J Pharmacokinet Biopharm; 1990 Apr; 18(2):103-20. PubMed ID: 2348378
[TBL] [Abstract][Full Text] [Related]
2. Bioequivalence: performance of several measures of rate of absorption.
Bois FY; Tozer TN; Hauck WW; Chen ML; Patnaik R; Williams RL
Pharm Res; 1994 Jul; 11(7):966-74. PubMed ID: 7937556
[TBL] [Abstract][Full Text] [Related]
3. Estimation of bioavailability on a single occasion after semisimultaneous drug administration.
Karlsson MO; Bredberg U
Pharm Res; 1989 Sep; 6(9):817-21. PubMed ID: 2813280
[TBL] [Abstract][Full Text] [Related]
4. Parametric and nonparametric population methods: their comparative performance in analysing a clinical dataset and two Monte Carlo simulation studies.
Bustad A; Terziivanov D; Leary R; Port R; Schumitzky A; Jelliffe R
Clin Pharmacokinet; 2006; 45(4):365-83. PubMed ID: 16584284
[TBL] [Abstract][Full Text] [Related]
5. A comparison between the semisimultaneous and the stable isotope techniques for bioavailability estimation of terbutaline in humans.
Bredberg U; Karlsson MO; Borgström L
Clin Pharmacol Ther; 1992 Sep; 52(3):239-48. PubMed ID: 1526079
[TBL] [Abstract][Full Text] [Related]
6. Bioequivalence: performance of several measures of extent of absorption.
Bois FY; Tozer TN; Hauck WW; Chen ML; Patnaik R; Williams RL
Pharm Res; 1994 May; 11(5):715-22. PubMed ID: 8058642
[TBL] [Abstract][Full Text] [Related]
7. In vivo evaluation of the semi-simultaneous method for bioavailability estimation using controlled intravenous infusion as an 'extravascular' route of administration.
Bredberg U; Karlsson MO
Biopharm Drug Dispos; 1991 Nov; 12(8):583-97. PubMed ID: 1801965
[TBL] [Abstract][Full Text] [Related]
8. Theoretical considerations in the calculation of bioavailability of drugs exhibiting Michaelis-Menten elimination kinetics.
Rubin GM; Tozer TN
J Pharmacokinet Biopharm; 1984 Aug; 12(4):437-50. PubMed ID: 6527233
[TBL] [Abstract][Full Text] [Related]
9. Performance and robustness of the Monte Carlo importance sampling algorithm using parallelized S-ADAPT for basic and complex mechanistic models.
Bulitta JB; Landersdorfer CB
AAPS J; 2011 Jun; 13(2):212-26. PubMed ID: 21374103
[TBL] [Abstract][Full Text] [Related]
10. Bioavailability of flumequine after semisimultaneous administration to veal calves.
Meijer BA; Ceyssens KG; de Jong WT; de Grève BI
Pharm Res; 1994 Jan; 11(1):117-21. PubMed ID: 8140041
[TBL] [Abstract][Full Text] [Related]
11. Concurrent intravenous administration of a labeled tracer to determine the oral bioavailability of a drug exhibiting Michaelis-Menten metabolism.
Rubin GM; Waschek JA; Pond SM; Effeney DJ; Tozer TN
J Pharmacokinet Biopharm; 1987 Dec; 15(6):615-31. PubMed ID: 3450845
[TBL] [Abstract][Full Text] [Related]
12. On the unphysical hypotheses in pharmacokinetics and oral drug absorption: Time to utilize instantaneous rate coefficients instead of rate constants.
Mavroudis PD; Kosmidis K; Macheras P
Eur J Pharm Sci; 2019 Mar; 130():137-146. PubMed ID: 30690188
[TBL] [Abstract][Full Text] [Related]
13. Assessment of dosing impact on intra-individual variability in estimation of parameters for basic indirect response models.
Krzyzanski W; Dmochowski J; Matsushima N; Jusko WJ
J Pharmacokinet Pharmacodyn; 2006 Oct; 33(5):635-55. PubMed ID: 16941234
[TBL] [Abstract][Full Text] [Related]
14. A novel extravascular input function for the assessment of drug absorption in bioavailability studies.
Weiss M
Pharm Res; 1996 Oct; 13(10):1547-53. PubMed ID: 8899849
[TBL] [Abstract][Full Text] [Related]
15. In silico predictions of gastrointestinal drug absorption in pharmaceutical product development: application of the mechanistic absorption model GI-Sim.
Sjögren E; Westergren J; Grant I; Hanisch G; Lindfors L; Lennernäs H; Abrahamsson B; Tannergren C
Eur J Pharm Sci; 2013 Jul; 49(4):679-98. PubMed ID: 23727464
[TBL] [Abstract][Full Text] [Related]
16. Truncated area under the curve as a measure of relative extent of bioavailability: evaluation using experimental data and Monte Carlo simulations.
Gaudreault J; Potvin D; Lavigne J; Lalonde RL
Pharm Res; 1998 Oct; 15(10):1621-9. PubMed ID: 9794507
[TBL] [Abstract][Full Text] [Related]
17. The effects of active metabolites on parameter estimation in linear mixed effect models of concentration-QT analyses.
Bonate PL
J Pharmacokinet Pharmacodyn; 2013 Feb; 40(1):101-15. PubMed ID: 23288469
[TBL] [Abstract][Full Text] [Related]
18. The influence of assay variability on pharmacokinetic parameter estimation.
Graves DA; Locke CS; Muir KT; Miller RP
J Pharmacokinet Biopharm; 1989 Oct; 17(5):571-92. PubMed ID: 2614686
[TBL] [Abstract][Full Text] [Related]
19. Population Pharmacokinetics of Posaconazole Tablets and Monte Carlo Simulations To Determine whether All Patients Should Receive the Same Dose.
Petitcollin A; Boglione-Kerrien C; Tron C; Nimubona S; Lalanne S; Lemaitre F; Bellissant E; Verdier MC
Antimicrob Agents Chemother; 2017 Nov; 61(11):. PubMed ID: 28848009
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
